Page 45 - 2021 Taiwan Food and Drug Administration Annual Report
P. 45
Section 4 working groups to formulate global drug
technical guidelines to keep up with inter-
Actively Participated in national standards and build a regulatory
International Events of environment that has international competi-
Medicine tiveness.
Introduction of the Policy II. Continued to participate in
APEC international confer-
TFDA continues promoting international ences
cooperation in pharmaceutical products and
actively participating in important interna- TFDA actively participates in the work
WLRQDO RUJDQL]DWLRQ DFWLYLWLHV VXFK DV WKH promoted by the APEC Regulatory Harmoni-
$VLD 3DFL¿F (FRQRPLF &RRSHUDWLRQ $3(& ]DWLRQ 6WHHULQJ &RPPLWWHH 5+6& DQG DFWV
and The International Council for Harmon- as a leading economy in promoting “Good
isation of Technical Requirements for Phar- 5HJLVWUDWLRQ 0DQDJHPHQW *50 ´ DQG UHJ-
PDFHXWLFDOV IRU +XPDQ 8VH ,&+ 3KDUPD- ularly reports the results of GRM promotion
ceutical Inspection Co-operation Scheme DW $3(& 5+6& LQWHUQDWLRQDO FRQIHUHQFHV
(PIC/S). TFDA is also working to strengthen which continues to make the country’s voice
bilateral and multilateral cooperation through heard on the global stage.
interaction and experience sharing with vari-
RXV LQWHUQDWLRQDO UHJXODWRU\ LQVWLWXWLRQV IXU- III. Conducted the 8th Joint Confer-
ther enhancing our international participation ence of Taiwan and Japan on
as well as the impact to the world. Medical Products Regulation
Implementation Strategy The 8th Joint Conference of Taiwan
and Japan on Medical Products Regulation
I. Expanded participation in ICH ZDV KHOG RQ 2FWREHU 'XH WR WKH
related meetings. &29,' SDQGHPLF WHOHFRQIHUHQFLQJ ZDV
FRQGXFWHG IRU WKH ¿UVW WLPH ZLWK WKH FRQIHU-
,Q UHFHQW \HDUV 7)'$ KDV EHHQ FRP- ence attendees in Japan. In addition to the
mitted to establishing international drug government officials from both Japan and
management regulations and promoting the 7DLZDQ WKHUH ZHUH DERXW SUDFWLWLRQHUV
harmonization of the country’s drug regu- from the medicine and medical equipment
lations and ICH guidelines. After officially industries in Taiwan and Japan attending the
becoming a member of the ICH regulations conference.
LQ 7)'$ H[SDQGHG LWV SDUWLFLSDWLRQ LQ
the ICH conference and worked with expert ,Q WKH PHHWLQJ UHSUHVHQWDWLYHV IURP
Taiwan and Japan shared their experience on
43
